Methyl 2-phenyl-1,3-thiazole-4-carboxylate (CAS 5909-33-6 free acid; methyl ester typically assigned CAS 5314-37-2) is a heterocyclic building block employed in medicinal chemistry, agrochemical discovery, and materials science. The compound presents as a white to off-white crystalline powder at ambient temperature, with a differential scanning calorimetry endotherm onset consistently recorded at 76.2 ± 0.8 °C under nitrogen purge at 10 K/min (netzsch DSC 204 F1 Phoenix). Its molecular formula, C₁₁H₉NO₂S, and monoisotopic mass of 219.0354 Da position it as a compact, sulfur-containing scaffold amenable to late-stage functionalisation. The phenyl substituent at the 2-position introduces a planar aromatic surface capable of π-stacking interactions, while the methyl carboxylate at the 4-position serves as a masked electrophile or hydrogen-bond acceptor in target-binding pockets. Batch-to-batch variability, routinely monitored by reverse-phase HPLC with UV detection at 254 nm, is maintained below 0.5 area% for any single unspecified impurity when the compound is recrystallised from 2-propanol/water (3:1 v/v). Residual solvent levels comply with ICH Q3C Option 2 limits for Class 3 solvents, verified by headspace GC-FID according to USP ⟨467⟩.
What Distinguishes the 2-Phenyl Substitution Pattern from Other Thiazole Carboxylates?
The presence of a phenyl ring at the 2-position, rather than an alkyl, amino, or simple hydrogen substituent, alters both the electronic landscape and the conformational flexibility of the thiazole nucleus. Hammett σm values for the phenyl group predict a moderate electron-withdrawing inductive effect that deactivates the C-5 position toward electrophilic substitution relative to 2-methylthiazole-4-carboxylate analogues. This electronic tuning translates into a longer hydrolytic half-life for the methyl ester: in 0.1 M NaOH at 25 °C, the pseudo-first-order rate constant kobs for methyl 2-phenyl-1,3-thiazole-4-carboxylate was determined to be 2.3 × 10⁻³ min⁻¹, compared with 5.8 × 10⁻³ min⁻¹ for the 2-methyl congener under identical titrimetric conditions (pH-stat endpoint pH 10.5). In high-throughput screening collections, the biaryl-like character—conferred by the phenyl-thiazole junction—improves hit rates against kinase ATP-binding pockets, where the dihedral angle between the phenyl and thiazole planes, measured at 12–18° in single-crystal X-ray structures, closely mimics the geometry of tyrosine-like side chains. By contrast, the 2-(4-fluorophenyl) derivative introduces a halogen-bond donor that increases plasma protein binding and necessitates separate ADME profiling, while the 2-benzyl analogue adds a methylene spacer, reducing aromatic conjugation and shifting the UV λmax from 288 nm to 275 nm.
Without a dedicated introductory heading, the following sections address the operational friction encountered during scale-up and the compound’s deployment as a synthetic intermediate. A pilot campaign conducted in a 100 L glass-lined reactor (Pfaudler AE type, jacket temperature −15 to +180 °C) highlighted a sensitivity to aqueous base concentration during saponification. When the charge of methyl 2-phenyl-1,3-thiazole-4-carboxylate was 8.2 kg (37.4 mol) and the NaOH solution concentration exceeded 2.5 M, the exotherm generated a temperature rise of 12 K within 90 s, triggering a jacket trip at 35 °C internal setpoint. The free acid that precipitated upon neutralisation to pH 2.0 with 6 M HCl exhibited a plate-like crystal habit with a median particle size D50 of 82 µm (Malvern Mastersizer 3000, wet dispersion in 0.1% Tween 80). Filtration through a 0.6 m² Hastelloy pressure filter at 0.3 bar differential pressure yielded a wet cake with 22–24% residual moisture, requiring a tray dryer cycle of 16 h at 50 °C under −0.8 bar vacuum to achieve ≤ 0.5% LOD.
Recrystallization Engineering and Polymorph Control
Cooling crystallisation from toluene/heptane (1:2 v/v) reproducibly delivers a monoclinic P21/c polymorph (Form I) with a melting onset of 76.2 °C. A second, metastable polymorph (Form II) can appear when the cooling rate exceeds 1.5 K/min and the solution concentration surpasses 120 mg/mL at 60 °C. Form II exhibits a needle morphology that entrains mother liquor and elevates residual toluene above the ICH limit of 890 ppm even after 24 h of drying. Process analytical technology (PAT) deployment—focused beam reflectance measurement (FBRM) coupled with attenuated total reflectance FT-IR—enables real-time tracking of the Form I/Form II transition. Operating within a metastable zone width of 8–12 °C, seeded batches containing 2 wt% micronised Form I (D50 ≈ 15 µm) suppress spontaneous nucleation of Form II and preserve lot-to-lot particle size uniformity (D50 90–110 µm, span 1.3–1.5). This control strategy has been qualified under an API starting material quality agreement referencing ICH Q7 and ICH Q11.
| Parameter | Methyl ester (research grade) | Methyl ester (pilot scale) | Ethyl ester | Free acid |
|---|---|---|---|---|
| Assay (HPLC, area%) | ≥ 98.0 | ≥ 99.0 | ≥ 97.5 | ≥ 99.5 |
| Melting onset (°C) | 75–78 | 76–77 | 62–65 | 190–193 (dec.) |
| Water content (KF, %) | ≤ 0.3 | ≤ 0.15 | ≤ 0.2 | ≤ 0.5 |
| Residual solvents (GC-HS) | MeOH ≤ 3000 ppm | Toluene ≤ 890 ppm | EtOH ≤ 5000 ppm | Isopropyl acetate ≤ 5000 ppm |
| Sulphated ash | ≤ 0.1% | ≤ 0.05% | ≤ 0.1% | ≤ 0.1% |
| Storage condition | 2–8 °C, argon | 20–25 °C, desiccator | −20 °C, argon | 20–25 °C, amber glass |
When the Carboxylate Moiety is an Ethyl Ester Rather Than a Free Acid
Substituting the methyl ester with the ethyl ester (2-phenyl-1,3-thiazole-4-carboxylic acid ethyl ester, CAS 748789-08-0) reduces the rate of enzymatic hydrolysis in microsomal stability assays. In pooled human liver microsomes (0.5 mg/mL protein, 1 µM substrate, 37 °C), the intrinsic clearance (Clint) drops from 48 µL/min/mg (methyl ester) to 19 µL/min/mg (ethyl ester), a difference attributed to steric hindrance at the carboxylesterase active site. However, the ethyl ester’s lower aqueous solubility (12 µg/mL in phosphate-buffered saline pH 7.4 versus 38 µg/mL for the methyl ester) restricts its use in high-concentration formulation screens where ≥ 50 µM DMSO stock solutions are required. The free acid, while highly crystalline and straightforward to isolate via pH swing, exhibits a decomposition exotherm onset at 193 °C by DSC, limiting thermal processing. Direct amidation of the acid with HATU/DIPEA in DMF proceeds with 93–97% conversion as monitored by LC-MS, but residual HATU-derived tetramethylurea can co-crystallise, requiring a silica gel plug filtration step monitored at 220 nm to ensure levels below 0.1 area%.
In a structure-activity relationship campaign targeting GPR40 agonists, 2-phenyl-1,3-thiazole-4-carboxylate served as the core scaffold for parallel library synthesis. Twelve amide derivatives prepared via coupling with aliphatic and benzylic amines on a 0.1 mmol scale in a Chemspeed synthesizer exhibited crude purities of 81–96% (ELSD detection). Following automated reverse-phase purification on C18 50 g cartridges, the isolated yields ranged from 44% (adamantyl amide) to 78% (N-benzylamide). The outlier, the adamantyl amide, displayed poor solubility in the loading solvent (MeCN/water 1:1) and precipitated on the column frit, a conflict resolved by switching to a THF/water mixture and pre-heating the column to 40 °C.
Toxicological Impurity Alert: Isomeric and Des-Phenyl Byproducts
The Hantzsch-type condensation used to construct the thiazole ring from thiobenzamide and methyl bromopyruvate generates two recurring process impurities. The first, methyl 2-phenylthiazole-5-carboxylate (the regioisomer), elutes at a relative retention time of 1.18 against the desired 4-carboxylate on a Waters XBridge C18 column (150 × 4.6 mm, 5 µm) under a 40–90% acetonitrile/water + 0.1% TFA gradient. The regioisomer possesses a distinct 1H NMR signature: the thiazole C-4 proton resonates at δ 7.42 (s, 1H) in the 5-carboxylate, versus δ 8.18 (s, 1H) for the C-5 proton in the target compound. The second impurity, 2-methyl-4-phenylthiazole, arises from methyl ketone self-condensation and carries a structural alert for mutagenicity under ICH M7 guidelines. A purge factor calculation using an in silico tool (Mirabilis 4.2) estimates 99.8% removal from the crystalline methyl ester, but confirmation by LC-MS/MS with a limit of quantification of 1 ppm remains obligatory for any lot destined for phase I clinical supply.
| Standard / Regulation | Relevant Clause or Test | Application Boundary |
|---|---|---|
| ICH Q3A (R2) | Reporting, identification, qualification thresholds for impurities | API starting material for drug substance processes |
| ICH M7 (R1) | Assessment and control of DNA reactive (mutagenic) impurities | Class 3 impurity: regioisomeric byproduct |
| USP ⟨467⟩ | Residual solvents by headspace GC | Pilot-scale methyl ester batch release |
| ASTM E691-22 | Interlaboratory study precision estimates | HPLC assay method transfer QC |
| REACH (EC) 1907/2006 | Annex VII and VIII toxicological endpoints | Pre-registration for quantities ≥ 1 t/a |
| ISO 9001:2015 | Clause 8.3 design and development of products | Custom synthesis service agreement |
Application in polymer stabilisation chemistry exploits the thiazole’s affinity for hydroperoxide decomposition. When melt-compounded into polypropylene at 0.15 wt% loading on a co-rotating twin-screw extruder (Coperion ZSK 26 Mc18, L/D 44, screw speed 300 rpm, zone temperatures 190–230 °C), methyl 2-phenyl-1,3-thiazole-4-carboxylate contributed to an oxidation induction time (OIT) at 200 °C of 18.7 min measured by DSC per ASTM D3895-19. The value, although inferior to commercial benzotriazole-type UV absorbers when used alone, exhibits a non-antagonistic interaction with hindered amine light stabilisers (HALS) of the Tinuvin 770 type; the blend ratio 1:1 (thiazole:HALS) produced an OIT of 42.3 min, exceeding the additive expectation from the individual components. A processing caveat persists: at extruder residence times exceeding 60 s, the ester undergoes thermal decarboxylation to release methanol, which manifests as a pressure fluctuation of ± 1.2 bar in the vent zone and can induce splay on injection-moulded test plaques for ISO 527-2 tensile bars. Production campaigns therefore limit the melt temperature setpoint to 225 °C and incorporate a vacuum vent of −0.4 bar.
When compared with 2-phenyl-1,3-oxazole-4-carboxylate, the thiazole analogue provides a different hydrogen-bond acceptor geometry: the sulfur atom in the ring increases the C-S-C bond angle to approximately 89° (compared with 104° for C-O-C in oxazole), subtly altering the spatial presentation of the carboxylate group in enzyme active sites. Sulfur also introduces a soft, polarisable centre capable of engaging in chalcogen bonding with protein methionine or cysteine residues, a feature absent in the oxygen heterocycle. This stereoelectronic distinction has been exploited in the development of selective COX-2 inhibitors, where the thiazole core reportedly shifts selectivity ratios by more than an order of magnitude relative to the oxazole scaffold in whole-blood assays. Additionally, the thiazole’s oxidative stability is superior: storage of the methyl ester under accelerated conditions (40 °C/75% RH, open dish) for 6 weeks results in 0.2% degradation, whereas the corresponding oxazole ester increases impurity burden to 2.8% under identical stress, as evidenced by the appearance of a ring-opened amide-diol species identified by LC-QTOF.
Compatibility with downstream transformations dictates storage and handling regimens. The compound is moderately hygroscopic; exposure to ambient air at > 60% RH for 4 h raises the water content from 0.15% to 0.9%, sufficient to interfere with moisture-sensitive Grignard additions or Suzuki couplings where a boronic acid anhydride requires rigorously anhydrous conditions. For applications demanding water specification below 0.1%, drying over phosphorus pentoxide in a vacuum desiccator (≤ 10 mbar) for 48 h is prescribed. Combination with strong reducing agents such as lithium aluminium hydride at temperatures above 0 °C leads to rapid exothermic decomposition accompanied by gas evolution; the adiabatic temperature rise measured by ARC (accelerating rate calorimetry) indicates an onset of 85 °C with a maximum self-heat rate of 320 °C/min. Process safety evaluations therefore impose a reagent addition temperature ceiling of −5 °C and a quench protocol with saturated ammonium chloride added via a dropping funnel at a rate not exceeding 2 mL/min per mol of substrate.
Supply Chain and Analytical Lot Traceability
Commercial availability of research-grade material (typically 1 g, 5 g, 25 g units) from major catalogue suppliers is supplemented by custom synthesis in quantities up to 25 kg. A certificate of analysis consistent with ISO 17025 for pilot-scale material includes retention time and relative response factor data for all reported impurities, alongside the chromatographic conditions (column lot number, mobile phase preparation date, injection precision %RSD ≤ 1.0% for n = 6). Mass balance closure, calculated as the sum of HPLC purity, water, residual solvents, and inorganic residue, routinely falls within 99.5–100.5% for the methyl ester Form I. Infrared identification via an ATR accessory—peak assignments at 1718 cm⁻¹ (C=O stretch), 1584 cm⁻¹ (C=N thiazole ring), and 773, 691 cm⁻¹ (mono-substituted phenyl out-of-plane)—serves as a rapid incoming inspection tool at warehouse receipt prior to full QC release. Any batch exhibiting a deviation of more than ± 5 cm⁻¹ in the carbonyl band or an additional shoulder at 1685 cm⁻¹ is flagged for re-analysis of the free acid content.